FDA Inspection 760537 — Biogenex Laboratories, Inc.

Biogenex Laboratories, Inc. — FEI 2936532

The FDA completed an inspection of Biogenex Laboratories, Inc. on Jan 6, 2012 in Fremont, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 6, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
Fremont, CA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
311721 CFR 820.70(i)Software validation for automated processes
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
369621 CFR 820.100(b)Documentation
419121 CFR 806.10(a)(1)Report of risk to health
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.